Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole

Clinical Pharmacology and Therapeutics
T AnderssonP Lundborg

Abstract

The effect of omeprazole treatment on diazepam plasma levels was studied in four slow and six rapid metabolizers of omeprazole. Single intravenous doses of diazepam (0.1 mg/kg) were administered after 1 week of oral treatment with omeprazole (20 mg) and placebo. This was a double-blind crossover study with randomized placebo and omeprazole treatments. Blood was collected up to 120 hours after diazepam dosing (still during one-daily omeprazole and placebo administration) for measurement of diazepam and its major metabolite desmethyldiazepam. The slow metabolizers of omeprazole also metabolized diazepam slowly, exhibiting only half the diazepam plasma clearance of the others. The mean clearance of diazepam was decreased 26% after omeprazole in the rapid metabolizers, whereas the slow group showed no apparent interaction. The mean plasma concentrations of desmethyldiazepam showed a more rapid formation in the rapid compared with the slow metabolizers, which is a logical consequence of the rate of diazepam metabolism.

Citations

May 1, 1992·Journal of Clinical Pharmacology·B OosterhuisP B Zuiderwijk
Feb 1, 1992·The Annals of Pharmacotherapy·M Gibaldi
Dec 1, 1992·British Journal of Clinical Pharmacology·P UngeJ P Idström
Apr 4, 1991·The New England Journal of Medicine·P N Maton
Feb 27, 1999·Journal of Clinical Pharmacy and Therapeutics·E Tanaka
Aug 21, 2001·Clinical Pharmacokinetics·T AnderssonK Röhss
Apr 2, 2003·Pharmacogenetics·Million ArefayeneDavid A Flockhart
May 4, 2004·Human & Experimental Toxicology·Blanca SinuésEsteban Mayayo
Mar 25, 2005·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·K H LiuJ G Shin
Jun 7, 2005·Expert Opinion on Emerging Drugs·Peter Wurm, John De Caestecker
Sep 2, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Henning BlumeBarbara S Schug
Jul 26, 2008·European Journal of Clinical Pharmacology·Staffan Ohlsson RosenborgErik Eliasson
Feb 9, 2012·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Masato OhbuchiTakashi Usui
Apr 3, 2014·BMC Evolutionary Biology·Ramatoulie E JanhaRobert T Walton
Jun 1, 1992·The Annals of Pharmacotherapy·M Gibaldi
Jan 1, 1991·European Journal of Clinical Pharmacology·T AnderssonC G Regårdh
Aug 1, 1994·British Journal of Clinical Pharmacology·T AnderssonD J Birkett
Nov 1, 1993·Human & Experimental Toxicology·R E Ferner, T R Allison
Feb 1, 1993·Scandinavian Journal of Gastroenterology·C CederbergL Olbe
Dec 3, 1999·Journal of Clinical Pharmacy and Therapeutics·E Tanaka
Mar 1, 1997·Journal of Clinical Gastroenterology·K G TolmanG L Ringham
Apr 21, 2001·BMC Gastroenterology·C EnderleU Grass
Jun 9, 2001·European Journal of Gastroenterology & Hepatology·L B Gerson, G Triadafilopoulos
Jun 26, 2004·Clinical Pharmacokinetics·Ichiro IeiriKenji Otsubo
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·J H Lin, A Y Lu
Jul 16, 2005·European Journal of Clinical Pharmacology·Jørgen G BramnessJørg Mørland
Dec 1, 1993·British Journal of Clinical Pharmacology·T AnderssonD J Birkett
Jun 1, 2004·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Kazuyuki Inoue
Sep 19, 2007·Journal of Clinical Pharmacy and Therapeutics·Xiang-Peng HuXin-Hua Xu
Jul 12, 2008·Molecular Nutrition & Food Research·Brian TomlinsonVivian W Y Lee
Jan 1, 2006·Toxicology Mechanisms and Methods·Shiew-Mei HuangLawrence J Lesko
May 22, 2008·British Journal of Clinical Pharmacology·Monika Schöller-GyüreRichard M W Hoetelmans
Mar 13, 1998·The Annals of Pharmacotherapy·M KusumotoM Shibakawa
Nov 15, 1997·Scandinavian Journal of Gastroenterology·E M VreeburgG N Tytgat
Jan 1, 1991·European Journal of Clinical Pharmacology·B G PollockC F Reynolds

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.